Dr. Xu is a biostatistician and Clinician Scientist at the Princess Margaret Cancer Center, and an Associate Professor in Biostatistics at the University of Toronto's Dalla Lana School of Public Health. As Principal-Investigator or co-Investigator, he has been involved in study design, data administration, statistical modeling development and data analysis on different clinical research and human genetic studies. He has published over 250 peer-reviewed papers in the field of statistics, bioinformatics, medical science and human genetics.

Dr. Xu’s research interests focus on clinical trial design and methodology, biostatistics and bioinformatics methodology, statistical genetics, and cancer clinical and translational research.
Awareness of the Harms of Continued Smoking Among Cancer Survivors.
Support Care Cancer. 2019 Nov 28;:
Eng L, Alton D, Song Y, Su J, Zhang Q, Che J, Farzanfar D, Mohan R, Krys O, Mattina K, Harper C, Liu S, Yoannidis T, Milne R, Abdelmutti N, Brown MC, Vennettilli A, Hope AJ, Howell D, Jones JM, Selby P, Evans WK, Xu W, Goldstein DP, Giuliani ME, Liu G
Mapping the University of Washington Quality of life questionnaire onto EQ-5D and HUI-3 indices in patients with head and neck cancer.
Head Neck. 2019 Nov 24;:
Stephens RF, Noel CW, Su JS, Xu W, Krahn M, Monteiro E, Goldstein DP, Giuliani M, Hansen AR, de Almeida JR
Prognostic importance of radiologic extranodal extension in HPV-positive oropharyngeal carcinoma and its potential role in refining TNM-8 cN-classification.
Radiother Oncol. 2019 Nov 08;144:13-22
Huang SH, O'Sullivan B, Su J, Bartlett E, Kim J, Waldron JN, Ringash J, de Almeida JR, Bratman S, Hansen A, Bayley A, Cho J, Giuliani M, Hope A, Hosni A, Spreafico A, Siu L, Chepeha D, Tong L, Xu W, Yu E
A chemical probe of CARM1 alters epigenetic plasticity against breast cancer cell invasion.
Elife. 2019 Oct 28;8:
Cai XC, Zhang T, Kim EJ, Jiang M, Wang K, Wang J, Chen S, Zhang N, Wu H, Li F, Dela Seña CC, Zeng H, Vivcharuk V, Niu X, Zheng W, Lee JP, Chen Y, Barsyte D, Szewczyk M, Hajian T, Ibáñez G, Dong A, Dombrovski L, Zhang Z, Deng H, Min J, Arrowsmith CH,...
Real-world health utility scores and toxicities to tyrosine kinase inhibitors in epidermal growth factor receptor mutated advanced non-small cell lung cancer.
Cancer Med. 2019 Oct 24;:
Jiang SX, Walton RN, Hueniken K, Baek J, McCartney A, Labbé C, Smith E, Chan SWS, Chen R, Brown C, Patel D, Liang M, Eng L, Sacher A, Bradbury P, Leighl NB, Shepherd FA, Xu W, Liu G, Hurry M, O'Kane GM
Evaluation of Older Age and Frailty as Factors Associated With Depression and Postoperative Decision Regret in Patients Undergoing Major Head and Neck Surgery.
JAMA Otolaryngol Head Neck Surg. 2019 Oct 17;:
Thomas CM, Sklar MC, Su J, Xu W, de Almeida JR, Gullane P, Gilbert R, Brown D, Irish J, Alibhai SMH, Goldstein DP
The Prevalence and Determinants of Return to Work in Nasopharyngeal Carcinoma Survivors.
Int J Radiat Oncol Biol Phys. 2019 Sep 27;:
So N, McDowell LJ, Lu L, Xu W, Rock K, Waldron J, Bernstein LJ, Chan HB, Huang SH, Giuliani M, Hope A, O'Sullivan B, Bratman SV, Cho J, Kim J, Jang R, Bayley A, Ringash J
Treatment outcomes in oropharynx cancer patients who did not complete planned curative radiotherapy.
Oral Oncol. 2019 Oct;97:124-130
Alfaraj F, Craig T, Huang SH, O'Sullivan B, Su J, Bayley A, Bratman S, Cho J, Giuliani M, Kim J, Ringash J, Waldron J, Hansen A, de Almeida J, Perez-Ordonez B, Weinreb I, Tong L, Xu W, Hope A
Clinical Outcomes of Surgically Unresectable Endometrial Cancers.
Am J Clin Oncol. 2019 Oct;42(10):777-782
Conway JL, Lukovic J, Ferguson SE, Zhang J, Xu W, Dhani N, Croke J, Fyles A, Milosevic M, Rink A, Rouzbahman M, Han K
Postoperative wound infections, neutrophil-to-lymphocyte ratio, and cancer recurrence in patients with oral cavity cancer undergoing surgical resection.
Oral Oncol. 2019 Oct;97:23-30
de Almeida JR, Yao CMKL, Ziai H, Staibano P, Huang SH, Hosni A, Hope A, Bratman SV, Monteiro E, Gilbert RW, Brown DH, Gullane PJ, Irish JC, Su J, Xu W, Goldstein DP

Pages

Clinician Scientist, Princess Margaret Cancer Centre

Principal Biostatistician, Princess Margaret Cancer Center, UHN
Associate Professor, Dalla Lana School of Public Health, University of Toronto